Patent ID: 7781442

Claim:
A method for treating amyloidosis associated with aberrant Aβ levels, said method comprising administering to a subject in need thereof an effective amount of a compound having a structure corresponding to Formula (VII): (A 1 -L A1 ) 0-1 -(B 1 )-L B1 -(C 1 )-L C1 -(D 1 ) (VII) and pharmaceutically acceptable salts thereof, wherein: A 1 is an optionally substituted 1,3-imidazole or a 1,2,3-triazole; B 1 is an optionally substituted phenyl or pyridyl; C 1 is an optionally substituted thiazole; D 1 is a substituted aryl; L A1 is a covalent bond; L B1 is a covalent bond; and L C1 is an amino linker linked at the 2-position of the thiazole.